Clinical trial participation by adolescents and young adults with cancer: A continued cause for concern?
Victoria White(The University of Texas MD Anderson Cancer Center), Michael Coory(Government of Western Australia Department of Health), Rosemary Harrup(University of Tasmania), Helen Bibby(Cancer Council Victoria), Gemma Skaczkowski(University of South Australia), Kate Thompson(Peter MacCallum Cancer Centre), Antoinette Anazodo(Sydney Children's Hospital), Lisa Orme(Peter MacCallum Cancer Centre), Marianne Phillips(Princess Margaret Hospital for Children), Rachel Conyers(Royal Children's Hospital), Ross Pinkerton(Royal Marsden NHS Foundation Trust), Michael Osborn, Wayne Nicholls(Queensland Children’s Hospital), Rick Walker(Children’s Health Queensland Hospital and Health Service)
Cited by 10
Related Papers
Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis
|The Lancet|2011|1.3k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
Stillbirths: recall to action in high-income countries
|The Lancet|2016|689